🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03770N101
- IPO
- 7/14/2023 · $17.00/share
Business: Apogee Therapeutics, Inc. is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications with high unmet need.
Company Contact
- CEO
- Michael Henderson
- CFO
- Jane Pritchett Henderson
- Headquarters
- 221 Crescent Street, Building 17, Suite 102b, Waltham, MA 02453
- Phone
- 650-394-5230
- Investor Relations
- Noel Kurdi · 650-394-5230 · noel.kurdi@apogeetherapeutics.com